$19.99 $23.88

Flavor: Blue Raspberry
Sold out


Pre-Workout Energy Shot | Redcon1 Fubar

Feeling tired? Need a boost? Redcon1 Fubar Energy Shot is here! This energy shot fulfills all your needs in one quick shot. With 400mg of Caffeine, it is packed with the energy you need to hit a workout or tackle the day! Due to the added Caffeine, this product enhances Mental focus and keeps your Mind focused on the task at Hand. Packed with Vitamins and Electrolytes, Redcon1 Fubar contains natural ingredients for the Body. This energy Shot is perfect in every way! Get your pack today. Introducing Redcon1 Fubar!!!!

Redcon1 Fubar Flavors

  • Blue Raspberry
  • Cherry Lime
  • Orange Crush

Redcon1 Fubar Benefits

  • Will Provide Lasting Energy
  • Packed With Vitamin B
  • Helps Provide Mental Focus & Acuity
  • 400 Milligrams Of Caffeine Per Bottle
  • Best Natural Energy Shot
  • Comes In A Variety Of Delicious Flavors
  • Bigger Than Competitors
  • Helps To Provide Extra Strength To Power Through Workouts

How Do I Take Redcon1 Fubar?

Redcon1 recommends drinking one (1) Fubar Shot whenever you’re in need of long lasting energy & focus.

Redcon1 Fubar Ingredients


Redcon1 Fubar Side Effects & Warnings

Keep out of reach of children. Do not exceed one Bottle per day. Assess tolerance by drinking ½ a Bottle. Do not combine with any other Caffeine containing products. This product is intended to be consumed by healthy adults 18 years of age or older. This product contains 400mg of Caffeine per bottle. Consult a Healthcare Professional before using this product. 


Schubert MM, Astorino TA, Azevedo JL Jr. The effects of caffeinated "energy shots" on time trial performance. Nutrients. 2013;5(6):2062-2075. Published 2013 Jun 6. doi:10.3390/nu5062062


Spradley BD, Crowley KR, Tai CY, et al. Ingesting a pre-workout supplement containing caffeine, B-vitamins, amino acids, creatine, and beta-alanine before exercise delays fatigue while improving reaction time and muscular endurance. Nutr Metab (Lond). 2012;9:28. Published 2012 Mar 30. doi:10.1186/1743-7075-9-28